http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007535508-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007535508-A |
| titleOfInvention | Composition for the treatment of hyperlipidemia |
| abstract | A composition for treating hyperlipidemia is provided. The present invention provides a composition for treating hyperlipidemia, the composition comprising acipimox as a first active ingredient and atorvastatin as a second active ingredient, or a pharmacologically acceptable salt thereof. , Ester, and solvate. The weight ratio of the first active ingredient to the second active ingredient is (10-80): 1. The composition is a tablet, capsule, granule, pill, drop pill. The combination of acipimox and atorvastatin calcium has a significant synergistic effect on lowering serum total cholesterol, serum triglycerides, and low density lipoprotein cholesterol. Furthermore, compared to the combination of acipimox and pravastatin, and acipimox and lovastatin, the combination of acipimox and atorvastatin has a stronger hypolipidemic action and is significantly superior in increasing high density lipoprotein cholesterol. [Selection figure] None |
| priorityDate | 2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.